CClinicalTrials.gg
CompletedNCT05298137Updated Nov 3, 2022

Passive Leg Raise for Pediatric Peripheral IV Placement

An interventional study of Passive Leg Raise in Anesthesia and Children, Only, sponsored by University of Saskatchewan. Completed at 1 site in Canada. Open to participants aged 3 Months to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-03.

Sponsored by University of Saskatchewan · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
234
Allocation
Randomized
Ages
3 Months to 17 Years
Sex
All
01

Study summary

The investigators hypothesize peripheral intravenous cannulation (insertion of tube into vein) will be facilitated (decreases the number of attempts) by a passive leg raise (raising the legs at the hip to 45 degree in a child laying on their back) in children.

Read the detailed description

Establishing peripheral intravenous (PIV) access in the pediatric population is challenging even in the hands of skilled practitioners.

A passive leg raise (PLR), raising a patient's legs to a 45 degree angle while supine, auto-transfuses the blood volume within the patient's lower extremities into the central venous compartment. Increasing the blood volume in the central venous compartment may also increase the volume and caliber of upper extremity peripheral veins. It remains to be studied whether a PLR increases peripheral vein diameter and if this would facilitate the placement of PIVs in the pediatric population.

02

Conditions studied

  • Anesthesia
  • Children, Only

Keywords

  • Pediatrics
  • Anesthesiology
  • Cannula
  • Anesthesia, Intravenous
  • Catheterization
03

In context

Lead sponsor

University of Saskatchewan is the lead sponsor of 237 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children ages 3 months to 17 years.
  • American Society of Anesthesiology (ASA) physical status 1-3 scheduled for elective surgical procedures under general anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Children undergoing procedures who already have adequate IV access (ie pre-established central or peripheral access).
  • Those greater than the age of 17, as this is the age limit for care at the Jim Pattison Children's Hospital.
  • Those with any lower limb pathology that limits range of motion.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
234 participants (actual)

Study arms

  • No intervention
    IV Cannulation Without Passive Leg Raise

    Patients will be randomized to either the passive leg raise (PLR) group or standard care (control group). In both groups baseline measurements of a peripheral vein diameter using ultrasound will be undertaken at the level of the left antecubital fossa with and without a proximally placed venous tourniquet. Those in the control group will then have a peripheral IV (PIV) placed in the ipsilateral arm as the baseline measurements, the number of attempts to successful PIV placement will be recorded. A repeat diameter assessment of the previously assessed vein, number of PIV attempts, and time to successful IV cannulation (measured as the time from skin puncture to successful IV cannulation) will be recorded.

  • Experimental
    IV Cannulation With Passive Leg Raise

    Patients will be randomized to either the passive leg raise (PLR) group or standard care (control group). In both groups baseline measurements of a peripheral vein diameter using ultrasound will be undertaken at the level of the left antecubital fossa with and without a proximally placed venous tourniquet. Those in the passive leg raise (PLR) group will have their legs elevated to 45 degrees until successful peripheral IV (PIV) placement. A repeat diameter assessment of the previously assessed vein, number of PIV attempts, and time to successful IV cannulation (measured as the time from skin puncture to successful IV cannulation) will be recorded.

    Procedure: Passive Leg Raise

Interventions

  • ProcedurePassive Leg Raise

    A passive leg raise (PLR) is defined as raising a patient's legs to a 45-degree angle at the hip while supine.

06

What researchers measure

Primary outcomes

  1. The number of attempts to successful catheterization.

    The study's primary outcome (number of peripheral IV attempts) will be analyzed using a Chi-square test.

    Time frame: During the intraoperative procedure.

Secondary outcomes

  1. The mean change in peripheral vein diameter following passive leg raise, assessed on ultrasonography.

    The change, if any, in peripheral vein diameter will be measured by comparing the diameter assessed by ultrasound at baseline and following leg raise. Results will be compared using the student's t test.

    Time frame: During the intraoperative procedure.

  2. Time from skin puncture to the confirmation of a functioning peripheral line.

    Time to vein cannulation will be compared using the student's t test.

    Time frame: Measured intraoperatively, an expected estimated average of 2 minutes.

  3. Provider perception of PLR on vein visualization.

    Chi-square testing will be used to evaluate provider perception of passive leg raise on vein visualization and palpation.

    Time frame: Immediately following successful cannulation in the experimental group.

  4. Provider perception of PLR on vein palpation.

    Chi-square testing will be used to evaluate provider perception of passive leg raise on vein visualization and palpation.

    Time frame: Immediately following successful cannulation in the experimental group.

07

Study locations

1 site
  • Jim Pattison Children's Hospital
    Saskatoon, Saskatchewan S7N 0W8, Canada
08

References and documents

Individual participant data

Plan to share: No — Aggregate results will be presented in manuscript form but no individual participant data (IPD) will be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05298137
Lead sponsor
University of Saskatchewan
Responsible party
Jonathan Gamble (Executive Director of Research for the Department of Anesthesiology, College of Medicine, University of Saskatchewan, University of Saskatchewan) — Principal investigator
First posted
Mar 28, 2022
Start date
May 10, 2022
Primary completion
Jul 30, 2022
Completion
Jul 30, 2022
Last update
Nov 3, 2022

Study contacts

Jonathan J Gamble, MD
principal investigator · Department of Anesthesiology, University of Saskatchewan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion